Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2018-07-20

Clinical Trial Update: Methylphenidate for Cocaine Dependence [Phase 2]

View source ↗

Summary

Phase 2 trial of methylphenidate for cocaine dependence was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Methylphenidate (Methylphenidate)

Snippet

Sponsor: ANRS, Emerging Infectious Diseases | Conditions: Substance-Related Disorders | Phase 2 | Status: WITHDRAWN